Table 3.
Factors | Sources | Targets | Effects | Mechanisms | References |
---|---|---|---|---|---|
OCN | • Osteoblast | • Endothelial cell |
• Protect vascular endothelial cell functions • Prevent atherosclerosis progression |
• Upregulate NO and NF-кB signals • Stimulate PI3K/Akt/eNOS pathway |
127,133,137 |
PDGF-BB | • Preosteoclast |
• Endothelial progenitor cell • Mesenchymal stem cell |
• Enhance capillary abundance • Stabilize tube formation • Mediate osteoblast differentiation |
• Trigger PI3K/Akt signaling cascade | 141,144,145 |
SLIT3 | • Osteoblast | • Endothelial cell |
• Promote tube formation and angiogenesis • Help bone remodeling and fracture repair |
• Activate ERK mitogen-activated protein kinase and Hippo signaling pathway | 150,151 |
VEGF |
• Osteoblast • Chondrocyte |
• Endothelial cell • Osteoprogenitor |
• Promote angiogenesis process • Modulate bone development and homeostasis |
• Induced by hypoxia via HIF-dependent pathway • Promote induction of β-catenin and activate Wnt signaling pathway |
156–158,160 |
FGF |
• Osteoblast • Chondrocyte |
• Endothelial cell |
• Promote angiogenesis process • Elevate vessel permeability |
• Induce EC proliferation, chemotaxis, and intercellular gap-junction communication | 165–167,170 |
MMP |
• Osteoclast • Osteoblast • Chondrocyte |
• Endothelial cell | • Contribute to vascular lumen formation |
• Via ERK, AKT, or PI3K and SRC pathways • Release angiogenic factors (VEGF, etc.) from matrix |
176–179,182 |
LCN-2 |
• Osteoblast • Adipocyte |
• Endothelial cell |
• Make for proper endothelial function • Involved in cardiovascular progression |
• Potentiated via IL-1β mediated pathway | 97,184,188,189 |
OCN osteocalcin, PDGF-BB platelet-derived growth factor-BB, SLIT3 slit homolog 3 protein, ERK extracellular signal regulated kinase, VEGF vascular endothelial growth factor, HIF hypoxia-inducible factor, FGF fibroblast growth factor, MMP matrix metalloprotease, LCN-2 lipocalin-2